Endometriosis Concepts

Endometriosis Concepts is maintaned by Dr. Dan Martin, the Executive and Medical Director of the Endometriosis Foundation of America, New York, a community member of the Virginia Commonwealth University Institutional Review Board, Richmond, and Professor Emeritus, School of Medicine, University of Tennessee Health Science Center, Memphis. Dr. Martin has studied endometriosis since 1970.

This site focuses on surgical science. That focus is not to detract from the suffering of those with endometriosis after years of neglect, roadblocks, gaslighting, and isolated islands of care. The focus is to help physicians prepare to provide improved care. -- adapted from Sawsan "Suzie" As-Sanie, September 12, 2023.

Resources

Endometriosis Concepts and Theories, monograph, 2024 (PDF)

Laparoscopic Appearance of Endometriosis, Atlas, First Edition, 1988 (PDF)

Laparoscopic Appearance of Endometriosis Color Atlas, Atlas, Second Edition, 1990-2023 Rev 7 (PDF)

Nonvisualized Palpable Bowel Endometriotic Satellites, Human Reprod, 2021, Open Access

“I’m looking through you”: What consumers and manufacturers need to know about non-invasive diagnostic tests for endometriosis, JEUD, 2023, Open Access.

Pain in Younger Women, JPAG, 2023, Author's draft.

Intraoperative Detection of Rectosigmoid Endometriosis, JMIG, 2023, Author's draft avialable on request.

Heal Endo: An Anti-Inflammatory Approach to Healing from Endometriosis, 2022, Katie Edmonds, at Amazon.

Jeff Arrington using a probe to identify endo, 2021, YouTube at 0.59 and 1.25.


Sections on this Page

IntroductionTheoriesEndometriosis Fertility IndexIs there a Stage 5?


Other Pages and Information

HomeEndometriosis ConceptsSite InformationLinks

Introduction

Please don’t refer to endometriosis, adenomyosis, or fibroids as “benign disease” - nope, not benign, they are “common and morbid."

- - - - - - - - - -

There are greater than 18 endometriosis theories and 400 concepts since 1855 BC covered in Endometriosis Concepts and Theories. Those includes only some of the more than 33,539 articles in PubMed (NIH), 440,000 articles in scholar.google.com and 291,450 array- and sequence-based data in the NIH GEO database. PubMed is acquiring more than five new citations daily. Endometriosis Concepts and Theories attempts to summarize this new knowledge in a timely fashion."


Endometriosis Concepts and Theories is periodically updated.

An endometriosis concept or theory may be useful in guiding research, explaining treatment, acting as a framework for education, and studying endometriosis. However, no concept or theory is completely adequate or determines if a treatment works. Treatment should be based on evidence of success and updated as knowledge changes.

Theories of develoment and progression can be divided into the Cell of Origin, methods of Dissemination, stimuli for Induction or Activation, a Window-of-Opportunity for induction or activation and the pathophysiological Transformation from an original Müllerian or non-Müllerian precursor cell to endometriosis. Those are opposed by the complimentary mechanisms of Inactivation and Clearance.

Cell of Origin

  • Müllerian, Endometrium
  • Müllerian, Embryonic Remnants
  • Müllerian, Tubal Metaplasia / Differentiation
  • Müllerian, Uterocervical Extension
  • Non-Müllerian, Stem Cell Differentiation

Dissemination (Metastasis) or In Situ

  • Retrograde Menstruation
  • Hematogenous Dissemination
  • Lymphatic Dissemination
  • Traumatic / Surgical Dissemination
  • Abnormal Fetal Müllerian Locations
  • Non-Müllerian Tissue
  • In Situ - Normal Fetal Müllerian Locations and Coelomic Metaplasia

Induction or Activation

  • Estrogen
  • Inflammation
  • Infection
  • Trauma
Window-of-Opportunity

There appears to be a window-of-opportunity for induction or activation during adolescence and early adulthood. This is associated with the initiation of estrogen production and neuroimmune maturation.

Transformation and Growth

The transformation from a cell of origin to deep infiltrating endometriosis or an ovarian endometrioma holds significant promise for research and development of therapeutic options. Transformation involves the local environment, inflammation, cellular histological modifications, biochemical changes, immunologic changes, apoptosis, autophagy, fibrosis, muscular metaplasia, cancer-associated driver mutations, angiogenesis, genetic predisposition, genetic changes, genetic dysregulation, epigenetic changes, and more.

Inactivation and Clearance

Growth is opposed by immunology, inactivation, apoptosis, epigenetic reversibility, and scavenging mechanisms including autophagy/clearance.

Theories and concepts are covered in:

---------------------------

Back to Top

History

Studying endometriosis is like nailing Jell-O to a tree.

- - - - - - - - - -

Clinical descriptions suggesting the presence of endometriosis were first written almost 4,000 years ago (Redwine 2012, Nezhat 2012). But a microscopic description did not occur until 1860 when Rokitansky (Batt RE, 2011, English translation on pages 209-211) described the histologic characteristics of endometriosis, adenomyosis, intracavitary myomas, and an ovarian malignancy or a papillary serous cystadenofibroma with psammoma bodies.

The difficulties in recognizing endometriosis were noted by Russell (1899) who discovered small, unseen, microscopic, intra-ovarian endometriosis and endometriosis hidden by ovarian adhesions. Sampson (1921 & 1927) subsequently found non-visualized, but palpable endometriosis within deep cul-de-sac adhesions. More recently laparoscopically non-visualized endometriosis has been found in the retroperitoneum (Moore 1988), tubes (McGuiness 2020), lymphatics including nodes (Taussig 1906, Sampson 1926, Javert 1949), large and small bowel (Martin 1990, Badescu 2016 and 2018, Roman 2020), appendix (Martin 1990), mesentery (Martin 1995), and omentum (Zinsser 1982).

Sampson published a series of articles from 1921 to 1940 in which he first used the term endometriosis in 1925. He discussed that endometriosis was different than endometrium "both in structure and in function," ectopic endometrium and endometriosis could coexist in one patient with a recognizable transition, and there was an associated inflamatory reaction similar to that seen in cancer and infection. Sampson concluded that retrograde flow does not explain all endometriosis and suggested additional theories such as celomic metaplasia or venous dissemination. He also discussed developmentally misplaced endometrial (Müllerian) tissue, why endometriosis was a better term than Müllerianosis, lymphatic dissemination, transplantation endometriosis, direct extension from perforating ovaries, tubal epithelium as the origin, metaplasia of peritoneal epithelium due to the stimulus of menstrual blood from perforating ovaries, metaplasia of the mesothelial lining of the processus vaginalis peritoneii or of the endothelial lining of dilated vessels, and extraperitoneal endometriosis remnants from Wolffian bodies. He described lesions including chocolate cysts, blebs, adenomyomatous infiltration, adherent surfaces, red raspberries, purple raspberries, blueberries, deep infiltration, inflammatory reactions, peritoneal pockets, and cancer arising in endometriotic implants.

Many of the anatomic phenotypes that Sampson described, in addition to look-alike lesions, can be seen in:

Fallon (1950) added to our understanding with clarification of colorless, amenorrheic lesions while Karnaky (1969) published an age dependent appearance of endometriosis starting with an initial water blister appearance.

Goldstein (1980) found petechial-like endometriosis and blebs in adolescents with chronic pain. Jansen (1986) subsequently confirmed Sampson's, Karnaky's, and Goldstein's finding with six different descriptions and also noted an additional six look-a-like lesions that were not endometriosis. Redwine (1988) then added the more descriptive term “near-contact laparoscopy” to update Goldstein’s “close-up view.”

---------------------------

Back to Top

Is there a stage 5 endometriosis?

Embrace the complexity of the disease.

Stage 5 Endometriosis

Michel Canis (1992) suggested using revised American Fertility Society (rAFS, 1985) score of >70 as Stage 5 for endometriosis.

This is also the 4B sub-score of the Endometriosis Fertility Index (EFI) (Adamson 2010). The EFI is a clinical tool used to predict pregnancy rates after endometriosis surgery. It is the only system that is predictive of fertility, but is not a staging system. The EFI has 6 levels and uses the 1985 rAFS staging system’s total and endometriosis sub-total score separately.

The rAFS (or rASRM) is the staging system most commonly used in surgical research. It is useful in comparing the gross appearance at the beginning of surgery and is somewhat predictive of surgical difficulty. But, it is not predictive of fertility, pain, the depth of infiltration, or the volume of infiltrating endometriosis.

The rAFS has 150 points. A score of 40 or higher is rASRM stage 4. The EFI separates stage 4 into scores for 4A (40 to 70 points) and 4B (71 to 150 points). Scores of 71 and higher are generally seen only with severe adhesions. Adhesions, a type of scar tissue, can block the pathway that the eggs use to get to the tube.

Adamson GD & Pasta DJ. Endometriosis fertility index: the new, validated endometriosis staging system. Fertil Steril 2010;94(5):1609–15

American Fertility Society. Revised American Fertility Society classification of endometriosis 1985. Fertil Steril 43(3):351-352, 1985

American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 67(5): 817-21, 1997

Canis M, Pouly JL, Wattiez A, et al. Incidence of bilateral adnexal disease in severe endometriosis (revised American Fertility Society [AFS], stage IV): should a stage V be included in the AFS classification? Fertil Steril 1992;57:691–692.

---------------------------

Back to Top

Endometriosis Fertility Index

David Adamson's Endometriosis Fertility Index (EFI) is a clinical tool used to predict pregnancy rates after endometriosis surgery. It is the only system that is predictive of fertility, but is not a staging system. The EFI has 6 levels and is based 50% on history, 30% on surgical findings at the completion of surgery, and 20% on the American Fertility Society (rAFS) total and endometriosis sub-total scores. The full EFI calculations are linked as a Figure at Endometriosis Fertility Index There is a short form of the calculations at Endometriosis Fertility Index Calculations.

The revised American Fertility Society (rAFS) and American Society of Reproductive Medicine (rASRM) staging systems are the staging systems most commonly used at surgery but are not predictive of fertility. The 1984 rAFS staging system was renamed the rASRM staging system in 1996 after that organization changed their name. The two are otherwise the same. Thgey can be used to describe the appearance at surgery and is somewhat predictive of surgical difficulty. The rAFS/rASRM has 150 points. A score 40 or higher is stage 4. The system separates stage 4 into scores for 4A (40 to 70 points) and 4B (71 to 150 points). Scores of 71 and higher are generally seen with severe adhesions. Adhesions are a type of scar tissue that can block the pathway that eggs use to get from the ovary to the tube.


Adamson GD & Pasta DJ. Endometriosis fertility index: the new, validated endometriosis staging system. Fertil Steril 2010;94(5):1609–15

American Fertility Society. Revised American Fertility Society classification of endometriosis 1985. Fertil Steril 43(3):351-352, 1985

American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 67(5): 817-21, 1997

---------------------------

Back to Top

Copyright 2016-2024

Updated October 16, 2024